Press releases
26/09/2025

Smart eyewear company, IXI, doubles down on ‘world’s first autofocus eyewear’ with European partnerships, readying itself for market entry

Front row: Niko Eiden (CEO, IXI) and Samuel Frei (CEO, Optiswiss) Back row: Mikko Ahlström (IXI), Alexander Dr. Potdevin (Optiswiss), Johannes Schubart (Optiswiss), Jürgen Ruppel (Optiswiss), Marko Ylinen (IXI), Henna Mäkinen (IXI)

  • IXI has acquired a lens manufacturing and development facility in Finland, strengthening its in-house capabilities
  • IXI has also entered into a long-term strategic partnership with Optiswiss, one of Europe’s leading independent lens manufacturers, to prepare a path to scale its liquid crystal autofocus lenses

Paris, 26 September 2025, 8:00am CESTIXI, the pioneer behind the world’s first autofocus glasses, today at SILMO, announced two strategic moves to further its mission of building the future of eyewear by strengthening its production pipeline in Europe. IXI has acquired the lens manufacturing and development facility of Finnsusp in Finland and has entered into a long-term strategic partnership with Optiswiss, one of Europe’s leading independent lens manufacturers.

This move marks a major milestone in IXI’s mission to transform vision correction. By disrupting the $200 billion eyewear market with dynamic lenses that automatically adapt to the wearer’s eyes, IXI is creating an entirely new category of eyewear.

With the new lens development facility in Finland, IXI gains not only a fully equipped manufacturing base but also the deep expertise of an established team. Integrating this proven capability with IXI’s proprietary liquid crystal technology will accelerate product development, enhance quality control, and establish a solid foundation for long-term innovation in smart eyewear.

Alongside the acquisition, IXI has entered a partnership with Optiswiss. Founded in 1937, Optiswiss has over 85 years of experience in high-precision optics and today operates one of Europe’s most advanced lens production facilities. The partnership combines IXI’s breakthrough autofocus lens technology with Optiswiss’s proven ability to manufacture at scale.

Niko Eiden, CEO and co-founder of IXI, says: For us, we’re intentionally building our production base in Europe. This is where the deepest expertise in optical precision and design lives, and we’ve brought together the people who know it best. These milestones are important steps on the path toward bringing our technology to the world. Our mission is simple: create eyewear that transforms how people see, without ever compromising on comfort or design.”

Riikka Järvinen, CEO of Finnsusp, says: “At Finnsusp, we’re proud to pass on our heritage and expertise in lens technologies to IXI. By combining our facilities with IXI’s advanced design and engineering, this acquisition will help power the next wave of innovation and play a defining role in shaping the future of eyewear. With this business transaction, our company will now focus on its international core business, especially the development and manufacturing of dry eye and contact lens care products.”


Samuel Frei, CEO of Optiswiss CEO, adds: “Optiswiss has stood for Swiss quality, precision, and craftsmanship for decades, powered by one of the most advanced production facilities in the heart of Europe. As an independent company, we are driven by innovation and excited to partner with IXI on a truly forward-thinking approach – one that has the potential to reshape the eyewear industry and set new standards for the future.”

A European pathway for the world’s first autofocus glasses

IXI is redefining eyewear with breakthrough autofocus lenses that adapt in real time, offering an innovative alternative to traditional bifocals and varifocals. By uniting proprietary innovation with world-class manufacturing, IXI is creating glasses that deliver comfort, natural appearance, and seamless technology - ushering in the new era of vision.

Together, these two developments provide IXI with the full spectrum of resources - an in-house innovation hub in Finland and a world-class production partner in Switzerland - establishing a European pathway from production to future consumer consumption of the world’s first autofocus glasses.


To sign up for the waitlist and hear about the latest IXI news, please visit: https://ixieyewear.com/


ENDS

The media kit is linked here, for any press enquiries, please contact ixi@ragency.com


About IXI

IXI was founded in 2021 in Espoo, Finland, with a simple premise: to create eyewear that provides optimal vision in every situation. Using cutting-edge technology, IXI glasses intelligently adapt to your eye movements, automatically focusing to help you see more—sharper—all within beautifully designed frames. Their first-generation product is currently in development, with more details to follow closer to launch. Sign up for early access here: https://ixieyewear.com/

About Optiswiss

Since their foundation in 1937, Optiswiss have remained locally based and fully independent. They manufacture all of their high-tech prescription lenses exclusively at their Basel site, ensuring every lens is 100% Swiss made. Their state-of-the-art production facilities and advanced automation guarantee the highest quality standards. As Switzerland’s number one lens manufacturer, they serve customers in more than 20 countries, powered by a team of over 250 people who share a passion for ophthalmic optics, deep expertise, and a commitment to growing sustainably with their partners.


About Finnsusp

Founded in 1978, family- and employee-owned Oy Finnsusp Ab (Piiloset) is a rapidly growing Finnish developer and manufacturer of unique contact lens care solutions and dry eye care products. All products are manufactured in facilities in Finland, and sold in over 35 countries in Europe, South and North America, the Middle East, and Africa. Today, the company employs 70 medical device professionals. Responsibility, Made-in-Finland, Development, High Quality, and Partnership are core values that guide the daily operation. Finnsusp is certified according to ISO 13485 and GMP standards. Find more information on https://finnsusp.fi